Related Research Articles
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo,New York. Founded by surgeon Roswell Park in 1898,the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center,which conducts clinical research on cancer as well as the development new drugs,provides advanced treatment for all forms of adult and pediatric cancer,and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019,the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Dartmouth Cancer Center (DCC) is a comprehensive cancer research center as designated by the National Cancer Institute. It is located at Dartmouth College and the Geisel School of Medicine in Hanover,New Hampshire. Its administrative offices are located within the Dartmouth-Hitchcock Medical Center in Lebanon,New Hampshire.
The Society for Immunotherapy of Cancer (SITC),previously known as the International Society for Biological Therapy of Cancer (iSBTc),is a professional society of scientists,academicians,researchers,clinicians,government representatives,and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently,SITC has more than 2,400 members,representing 22 medical specialties from 42 countries around the world,who are engaged in the research and treatment of cancer.
The University of Chicago Medicine Comprehensive Cancer Center is a collaborative cancer research center based in Hyde Park,Chicago,United States. The Comprehensive Cancer Center is affiliated with the University of Chicago.
Jonathan S. Berek, MD MMS is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine,Director of the Stanford Women's Cancer Center,and Senior Advisor,Stanford Cancer Institute. He is a recent past Fellow in the Stanford Distinguished Careers Institute.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
Michael A. Caligiuri is an American physician scientist focused on oncology and immunology. He is currently the president of the City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He was elected president of the American Association for Cancer Research,the world's largest cancer research organization,for 2017–2018. He was previously the CEO of the James Cancer Hospital (2008-2017),Director of the Comprehensive Cancer Center (2003-2017),and Director of the Division of Hematology-Oncology (2000-2008) at the Ohio State University. He was elected to the United States National Academy of Medicine in 2018.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore,MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Weiping Zou is the Charles B. de Nancrede Professor of Pathology,Immunology,Biology,and Surgery at the University of Michigan. He is a scientist noted for his work regarding understanding the nature of human tumor immune responses and developing mechanism-informed combination therapies for cancer. He has developed an international reputation in human tumor immunosuppressive mechanisms in the tumor microenvironment.
Miram Merad is a French-Algerian professor in Cancer immunology and the Director of the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York,NY. She is the corecipient of the 2018 William B. Coley Award for Distinguished Research in Basic Immunology and a member of the United States National Academy of Sciences and the National Academy of Medicine.
Duane A. Mitchell is an American physician-scientist and university professor. He is currently employed at the University of Florida College of Medicine,in Gainesville,Florida as the Assistant Vice President for Research,Associate Dean for Translational Science and Clinical Research,and Director of the University of Florida (UF) Clinical and Translational Science Institute. He is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery. and co-director of the Preston A. Wells Jr. Center for Brain Tumor Therapy. Mitchell is also the founder,President,and Chairman of iOncologi,Inc.,a biotechnology company in Gainesville,FL specializing in immuno-oncology.
Ernst Robert Lengyel is an American gynecologic oncologist. Lengyel is the Arthur L. and Lee G. Herbst Professor of Obstetrics and Gynecology at the University of Chicago. Lengyel directs the Ovarian Cancer Research Laboratory,a translational research laboratory focused on understanding ovarian cancer metastasis and on developing and testing new treatments for ovarian cancer. In this role,Lengyel and his research team began to investigate the role of the fallopian tube in ovarian cancer as the cells more closely resemble those in the fallopian tube rather than the ovary.
Antoni Ribas is a Spanish American physician–scientist. He is a Professor of Medicine,Surgery,and Molecular and Medical Pharmacology at the University of California,Los Angeles (UCLA) and Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center. Ribas served as president of the American Association for Cancer Research (AACR) in 2021–2022.
Bradley J. Monk is an American gynecologic oncologist,academician and researcher. He is a Professor on the Clinical Scholar Track in the Department of Obstetrics and Gynecology at the University of Arizona College of Medicine in Phoenix,Arizona,as well as at the Creighton University School of Medicine in Omaha,Nebraska. He also serves as Director of the Division of Gynecologic Oncology at the St. Joseph's Hospital and Medical Center in Phoenix.
Beth Young Karlan is an American gynecologic oncologist. In 2008,she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012,Karlan was appointed by the White House to serve on the National Cancer Advisory Board,and in 2015,she was elected to the National Academy of Medicine.
Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.
George Coukos is a physician-scientist in tumor immunology,professor and director of the Ludwig Cancer Research Lausanne Branch and director of the Department of oncology UNIL-CHUV of the University of Lausanne and the Lausanne University Hospital in Lausanne,Switzerland. He is known for his work on the mechanisms by which tumors suppress anti-cancer immune responses,and the role of the tumor vasculature in that suppression. In addition to his work in ovarian cancer,the combinatorial immune therapies proposed by Professor Coukos have been successfully tested and approved for lung,liver and kidney cancers.
Philip Greenberg is a professor of medicine,oncology,and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.
Mary L. "Nora" Disis is an American physician-oncologist and the editor in chief of JAMA Oncology.
References
- ↑ Staff (December 17, 2020). "Dr. Adekunle Odunsi Named New Director of Comprehensive Cancer Center | BSD Diversity". voices.uchicago.edu.
- ↑ Drury, Tracey (April 22, 2016). "Buffalo was 'love at first sight'". Buffalo Business First. Archived from the original on May 28, 2021. Retrieved May 28, 2021.
- ↑ "Adekunle O. Odunsi MD, PhD". medicine.buffalo.edu. Retrieved May 28, 2021.
- 1 2 "Dr. Kunle Odunsi Named Chair of Gynecologic Oncology at Roswell Park Comprehensive Cancer Center". roswellpark.org. June 24, 2010. Retrieved May 28, 2021.
- ↑ "Dr. Kunle Odunsi Earns Team Science Award for Work With World-Renowned Immunologist". roswellpark.org. November 14, 2020. Retrieved May 28, 2021.
- ↑ "2 Roswell Park Faculty Receive Prestigious Awards; Colleagues Named to Professional Association Board". roswellpark.org. February 10, 2012. Retrieved May 28, 2021.
- ↑ "Roswell Park Physician Kunle Odunsi Recognized for his National Leadership". roswellpark.org. October 25, 2016. Retrieved May 28, 2021.
- ↑ "Roswell Park Deputy Director Named to NIH Immunology Grant Review Board". roswellpark.org. July 27, 2017. Retrieved May 28, 2021.
- ↑ "NAM Member Class of 2018". nam.edu. 2018. Retrieved May 28, 2021.
- ↑ "Kunle Odunsi, MD, PhD, FRCOG, FACOG, Elected to Lead AACR Immunology Working Group". ascopost.com. January 25, 2020. Retrieved May 28, 2021.
- ↑ "Roswell Park Deputy Director Picked as Board Member for Influential Immunotherapy Organization". roswellpark.org. June 17, 2020. Retrieved May 28, 2021.
- ↑ Rubin, Gretchen (December 17, 2020). "Adekunle Odunsi named new director of UChicago Medicine Comprehensive Cancer Center". uchicagomedicine.org. Retrieved May 28, 2021.
- ↑ "Kunle Odunsi, M.D., Ph.D., FRCOG, FACOG CV" (PDF). unmc.edu. Retrieved May 28, 2021.
